Parker-Hannifin (PH) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

Columnist Anna Jeter writes that, despite any setbacks, people with pulmonary hypertension should continue to take charge of their care.